QA: UroGen Pharma Ltd. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001668243_2023_UroGen_Pharma_Ltd.pdf

Logs

Graph

Absolute values for 0001668243, UroGen Pharma Ltd.

  xvar xval
0 AssetsCurrent 128,907,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,297,000
3 remainder_Assets 5,415,000
4 LiabilitiesCurrent 23,916,000
5 LiabilitiesNoncurrent 99,123,000
6 remainder_Liabilities 101,941,000
7 CostOfGoodsAndServicesSold 7,654,000
8 SellingGeneralAndAdministrativeExpense 82,838,000
9 ResearchAndDevelopmentExpense 52,906,000
10 remainder_Expenses 31,752,000
11 remainder_Revenues 65,367,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -82,000
  yvar yval
0 Assets 135,619,000
1 Liabilities 224,980,000
2 Expenses 175,150,000
3 Revenues 65,367,000
4 StockholdersEquity -89,361,000
5 NetIncome -109,783,000
6 ComprehensiveNetIncome -109,824,000
7 BaseVar 300,599,000
8 EconomicCapitalRatio -1.46

Edgar->Model Mapping

Feature Distribution

Change over Time